| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905
The Ewing’s sarcoma (EWS) proto-oncogene can give rise to a variety of different tumors because of the generation of transforming EWS fusion proteins upon chromosomal translocation. However, the cellular function of the EWS protein itself was hitherto not established. We show that EWS is a nuclear protein, whose nuclear localization is dependent upon its transactivating NH2 terminus. EWS COOH-terminal amino acids suppress this NH2-terminal activation domain in the context of a Gal4 fusion protein, which may explain why none of the EWS fusion proteins in cancer cells contains the EWS COOH terminus. Furthermore, EWS expression enhances c-fos, Xvent-2, and ErbB2 promoter activity in a cell-type-dependent manner, indicating that EWS is a transcriptional regulator. Also, the EWS protein stimulates transcription mediated by the COOH-terminal transactivation domain of the cofactor CREB-binding protein (CBP). Coimmunoprecipitation experiments demonstrate that EWS forms a complex with CBP and the homologous p300 protein. A COOH-terminal region of EWS is both required for the physical interaction with CBP/p300 and sufficient to mediate c-fos activation. In addition, suppression of CBP/p300 function by the adenoviral E1A protein abolishes c-fos activation by EWS, indicating that EWS-mediated gene regulation depends on CBP/p300. In conclusion, the nuclear EWS proto-oncoprotein can function as a transcriptional cofactor in conjunction with CBP/p300.
This article has been cited by other articles:
|
|
 |
|
  A. Y. Tan and J. L. Manley The TET Family of Proteins: Functions and Roles in Disease J Mol Cell Biol, September 24, 2009; (2009) mjp025v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Anumanthan, S. K. Halder, D. B. Friedman, and P. K. Datta Oncogenic Serine-Threonine Kinase Receptor-Associated Protein Modulates the Function of Ewing Sarcoma Protein through a Novel Mechanism. Cancer Res., November 15, 2006; 66(22): 10824 - 10832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Law, K. L. Cann, and G. G. Hicks TLS, EWS and TAF15: a model for transcriptional integration of gene expression Brief Funct Genomic Proteomic, March 1, 2006; 5(1): 8 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Kasper, T. Fukuyama, M. A. Biesen, F. Boussouar, C. Tong, A. de Pauw, P. J. Murray, J. M. A. van Deursen, and P. K. Brindle Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development Mol. Cell. Biol., February 1, 2006; 26(3): 789 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zou, H. Ichikawa, M. L. Blackburn, H.-M. Hu, A. Zielinska-Kwiatkowska, Q. Mei, G. J. Roth, H. A. Chansky, and L. Yang The Oncogenic TLS-ERG Fusion Protein Exerts Different Effects in Hematopoietic Cells and Fibroblasts Mol. Cell. Biol., July 15, 2005; 25(14): 6235 - 6246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Alex and K. A. W. Lee RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains Nucleic Acids Res., March 2, 2005; 33(4): 1323 - 1331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Rorie and B. E. Weissman The Ews/Fli-1 Fusion Gene Changes the Status of p53 in Neuroblastoma Tumor Cell Lines Cancer Res., October 15, 2004; 64(20): 7288 - 7295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Rorie, V. D. Thomas, P. Chen, H. H. Pierce, J. P. O'Bryan, and B. E. Weissman The Ews/Fli-1 Fusion Gene Switches the Differentiation Program of Neuroblastomas to Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors Cancer Res., February 15, 2004; 64(4): 1266 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Mitsiades, N. S. Mitsiades, C. J. McMullan, V. Poulaki, R. Shringarpure, T. Hideshima, M. Akiyama, D. Chauhan, N. Munshi, X. Gu, et al. Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications PNAS, January 13, 2004; 101(2): 540 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Takahashi, F. Higashino, M. Aoyagi, K. Yoshida, M. Itoh, S. Kyo, T. Ohno, T. Taira, H. Ariga, K. Nakajima, et al. EWS/ETS Fusions Activate Telomerase in Ewing's Tumors Cancer Res., December 1, 2003; 63(23): 8338 - 8344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nakatani, K. Tanaka, R. Sakimura, Y. Matsumoto, T. Matsunobu, X. Li, M. Hanada, T. Okada, and Y. Iwamoto Identification of p21WAF1/CIP1 as a Direct Target of EWS-Fli1 Oncogenic Fusion Protein J. Biol. Chem., April 18, 2003; 278(17): 15105 - 15115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Gusterson, E. Jazrawi, I. M. Adcock, and D. S. Latchman The Transcriptional Co-activators CREB-binding Protein (CBP) and p300 Play a Critical Role in Cardiac Hypertrophy That Is Dependent on Their Histone Acetyltransferase Activity J. Biol. Chem., February 21, 2003; 278(9): 6838 - 6847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Araya, K. Hirota, Y. Shimamoto, M. Miyagishi, E. Yoshida, J. Ishida, S. Kaneko, M. Kaneko, T. Nakajima, and A. Fukamizu Cooperative Interaction of EWS with CREB-binding Protein Selectively Activates Hepatocyte Nuclear Factor 4-mediated Transcription J. Biol. Chem., February 7, 2003; 278(7): 5427 - 5432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Laflamme, C. Filion, J. A. Bridge, M. Ladanyi, M. B. Goldring, and Y. Labelle The Homeotic Protein Six3 Is a Coactivator of the Nuclear Receptor NOR-1 and a Corepressor of the Fusion Protein EWS/NOR-1 in Human Extraskeletal Myxoid Chondrosarcomas Cancer Res., January 15, 2003; 63(2): 449 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Haro and R. Janknecht Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter Nucleic Acids Res., July 1, 2002; 30(13): 2972 - 2979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ohkura, H. Yaguchi, T. Tsukada, and K. Yamaguchi The EWS/NOR1 Fusion Gene Product Gains a Novel Activity Affecting Pre-mRNA Splicing J. Biol. Chem., January 4, 2002; 277(1): 535 - 543. [Abstract] [Full Text]
|
|
|
|
|
|
H. Kovar, G. Jug, C. Hattinger, L. Spahn, D. N. T. Aryee, P. F. Ambros, A. Zoubek, and H. Gadner The EWS Protein Is Dispensable for Ewing Tumor Growth Cancer Res., August 1, 2001; 61(16): 5992 - 5997. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
